The forecasted trend for the import of Phenazone to France indicates a consistent decline over the next five years, decreasing from $576.29 thousand in 2024 to $206.09 thousand by 2028. As we transition from 2023 into future projections, this represents a significant downward trajectory.
Year-on-year variations show a decline of approximately 16.54% from 2024 to 2025, 19.46% from 2025 to 2026, 23.65% from 2026 to 2027, and 30.34% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over the five-year period indicates a sustained negative growth rate averaging around -24.1% annually.
Future trends to watch for:
- Potential regulatory changes affecting pharmaceutical imports.
- Fluctuations in global Phenazone production and pricing.
- Shifts in local demand due to evolving medical practices or alternative drugs.
